Dr. Rainer Boger – L-Arginine Expert

Dr. Rainer Boger

Dr. Rainer Böger received his medical training at Hannover Medical School in Hannover, Germany. He received his postgraduate training in Internal Medicine and Pharmacology both in Hannover and at Stanford University School of Medicine in Stanford, CA. He is currently the Professor of Clinical Pharmacology and Director of the Institute of Clinical Pharmacology and Toxicology at Hamburg University Medical Center, Germany. He is also Director of the Clinical Trial Center North at Hamburg University.

Dr. Böger’s scientific work centers on the early diagnosis and prevention of cardiovascular-related diseases. He has dedicated more than two decades of academic research related to L-arginine and its influence on the body’s ability to produce nitric oxide. His major achievements are the discovery that ADMA (asymmetric dimethylarginine) is a risk marker of vascular disease and the utilization of L-arginine to prevent vascular dysfunction and disease. Dr. Böger regularly collaborates with renowned institutions like the Mayo Clinic and Stanford University Medical Center and has documented his knowledge in more than 200 scientific articles, of which 130 exclusively cover the roles of ADMA and L-arginine in cardiovascular and metabolic diseases.

Dr. Böger has dedicated 21 years of academic research in basic science and clinical studies related to L-arginine and its influence on the body’s ability to produce NO. His major achievements are the discovery that ADMA (asymmetric dimethylarginine) is a risk marker of vascular disease and the utilization of L-arginine to prevent vascular dysfunction and disease.

Dr. Böger’s extensive knowledge, expertise, and ongoing research clearly set him apart as one of the world’s leading L-arginine experts. It’s an honor to have Dr. Böger as part of the Synergy WorldWide team.